• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Equipment & SuppliesPrecipio
    Picture of Precipio logo

    PRPO — Precipio News Story

    $20.010.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $35.82m
    • Enterprise Value
      $33.92m
    • Revenue
      $24.05m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PRPO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PRPO Dividends
    All News

    NASDAQ RESUMED AT 09:37 AM

    Picture of Precipio logoPrecipio
    03/05/2021 14:37
    NASDAQ RESUMED  PRPO.O  AT 09:37 AM
    

    Recent news on Precipio

    See all news
    • Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive

      14/08/2026 21:10
    • Precipio Q1 revenue rises on higher pathology sales

      14/05/2026 22:31
    • Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%

      25/02/2026 14:44
    • Brief: Precipio Identifies Unauthorized Access To Isolated Storage No Operational Impact

      04/12/2025 13:14
    • Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers

      14/11/2025 21:39

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.